Featured Articles
 
FDA Issues Safety Alert for Use of Hydroxychloroquine, Chloroquine for COVID-19
The FDA warned against the use of hydroxychloroquine and chloroquine outside of the hospital setting or clinical trials due to safety risks.
Read more
 
 
Famotidine Trial Underway in NYC for COVID-19 Treatment
Famotidine, the active compound in an OTC heartburn drug, may disable a key enzyme that COVID-19 uses to replicate.
Read more
Read More
 
The Importance of Early Treatment for Shingles
Sarilumab Trial for Treatment of COVID-19 to Include Only ‘Critical’ Patients
AGA Releases Expert Commentary for IBD Management During COVID-19
Insulin Affordability Options Expand During COVID-19